Carboxypeptidase [EPC]

285 reported adverse events

Drugs of this class: GLUCARPIDASE

These side effects are most commonly reported by patients taking drugs of the Carboxypeptidase [EPC] class:

# Side effect Count
0 OFF LABEL USE 68
1 UNDERDOSE 57
2 LABORATORY TEST INTERFERENCE 48
3 DRUG EFFECT INCOMPLETE 33
4 TOXICITY TO VARIOUS AGENTS 30
5 ACUTE KIDNEY INJURY 28
6 BLOOD CREATININE INCREASED 28
7 REBOUND EFFECT 28
8 DRUG INEFFECTIVE 23
9 RENAL FAILURE 23
See all common reactions for Carboxypeptidase [EPC]

Drugs of the Carboxypeptidase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LABORATORY TEST INTERFERENCE 48 0.0681
1 LEUKAEMIC LYMPHOMA 1 0.0294
2 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2 0.0177
3 FALSE POSITIVE INVESTIGATION RESULT 14 0.0162
4 OSTEOSARCOMA METASTATIC 1 0.0115
5 DRUG CLEARANCE DECREASED 7 0.0073
6 CRYSTAL NEPHROPATHY 3 0.0070
7 CRYSTALLURIA 2 0.0050
8 REBOUND EFFECT 28 0.0040
9 CARDIORENAL SYNDROME 1 0.0022
See all enriched reactions for Carboxypeptidase [EPC]